All stock lists
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
5.05+1.34 (+36.12%)
Market cap
$13.3M
Insider Score
Health Score
Analyst consensus
Listed since
Jul 27, 2018
Website
Insider Score
––Not scored
ADIL Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ADIL Stock Insider Trading Activity
ADIL stock’s insider trading shows no open-market insider trades by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Davidson Matt CEO | Award | 232,417 | — | — | 377% | 294,064 | Oct 28, 2026 | — | Form 4 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.